銀禧科技(300221.SZ)收到參股子公司瑞新投資退回實繳資本款750萬元
格隆匯2月21日丨銀禧科技(300221.SZ)公佈,公司近日收到參股30%的參股公司樟樹市瑞新投資管理中心(有限合夥)(“瑞新投資”)退回的實繳資本款共計750萬元。
由於受經濟形勢、投資環境以及新能源汽車行業發展情況等諸多因素的影響,瑞新投資在投資蘇州妙益科技股份有限公司後,暫未有其他合適的投資項目,瑞新投資召開合夥人會議,會議決定將瑞信投資部分賬面資金共計人民幣2500萬元按實繳出資比例暫先退回給各合夥人。
銀禧科技持有瑞新投資30%股份,因此銀禧科技共計收到瑞新投資退回的750萬元實繳資本。此次瑞新投資退回實繳資本不影響瑞新投資的註冊資本,其註冊資本仍為1億元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.